A missense variant of PLIN2 (Ser251Pro) was associated with a trend toward reduced liver fat accumulation in humans, although the variant is not associated with MASLD (at that time, nonalcoholic fatty liver disease (NAFLD)) in several cohorts (7). Here, PLIN2 is linked to metabolic dysfunction-associated steatotic liver disease.